MIRM - CIK 0001759425
Mirum Pharmaceuticals, Inc. (MIRM) reported net income of -$23.36M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$23.36M | +73.4% |
| FY 2024 | -$87.94M | +46.2% |
| FY 2023 | -$163.41M | -20.5% |
| FY 2022 | -$135.66M | -61.5% |
| FY 2021 | -$83.99M | +18.7% |
| FY 2020 | -$103.27M | -96.5% |
| FY 2019 | -$52.55M | - |
Mirum Pharmaceuticals, Inc. (MIRM) reported net income of -$23.36M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Mirum Pharmaceuticals, Inc.'s net income grew from -$52.55M to -$23.36M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.